Skip to main content
OpenTrials

Clinical trial condition

Philadelphia Chromosome

Explore clinical trials studying Philadelphia Chromosome. Study availability and eligibility vary by location and protocol.

31 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Philadelphia Chromosome trial results

Completed

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

NCT00171249

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +23 more
Locations
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • New York Presbyterian Hospital New York, United States
  • Oregon Health & Sciences University Portland, Oregon, United States
  • MD Anderson Cancer Center, University of Texas Houston, Texas, United States
View Trial Details
Completed

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

NCT00171223

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +20 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • H. Lee Moffet Cancer Center & Research Institute/Univ of South Florida Tampa, Florida, United States
  • Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 28 locations
View Trial Details
Completed

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

NCT00171158

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +18 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Faber Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Poitiers, France
View Trial Details
Completed

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT02130557

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 189 locations
View Trial Details
Completed

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

NCT01243489

Conditions
Behavior, Bone Marrow Diseases, Chromosome Aberrations, +19 more
Locations
  • Onkologische Schwerpunktpraxis Celle Celle, Germany
  • Onkozentrum Dresden, Gemeinschaftspraxis Dres. Göhler & Dörfel Dresden, Germany
  • Gemeinschaftspraxis Hämatologie - Onkologie, BAG Freiberg-Richter / Jacobasch / Illmer / Wolf Dresden, Germany
  • Gemeinschaftspraxis für Hämatologie und Onkologie Erfurt, Germany
View all 23 locations
View Trial Details
Completed

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

NCT00261846

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • HealthONE Presbyterian Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 111 locations
View Trial Details

Related conditions